The forecasted number of multidrug-resistant tuberculosis (MDR-TB) cases started on treatment in India shows a steady increase from 74.52 thousand in 2024 to 91.79 thousand in 2028. In 2023, actual cases were lower, indicating a growing challenge in managing MDR-TB. Year-on-year growth rates: 2024 to 2025: 5.87%, 2025 to 2026: 5.5%, 2026 to 2027: 5.16%, and 2027 to 2028: 4.85%. The compound annual growth rate (CAGR) from 2024 to 2028 is approximately 5.3%.
Future trends to watch for include:
- Strengthening public health infrastructure to manage increasing cases.
- Enhancing research for better treatment options and drug resistance management.
- Continuous monitoring of MDR-TB incidence for timely policy adjustments.
